Phenotypic heterogeneity has been observed among mesenchymal stem/stromal cell (MSC) populations, but specific genes associated with this variability have not been defined. To study this question, we analyzed two distinct isogenic MSC populations isolated from umbilical cord blood (UCB1 and UCB2). The use of isogenic populations eliminated differences contributed by genetic background. We characterized these UCB MSCs for cell morphology, growth kinetics, immunophenotype, and potential for differentiation. UCB1 displayed faster growth kinetics, higher population doublings, and increased adipogenic lineage differentiation compared to UCB2. However, osteogenic differentiation was stronger for the UCB2 population. To identify MSC-specific genes and developmental genes associated with observed phenotypic differences, we performed expression analysis using Affymetrix microarrays and compared them to bone marrow (BM) MSCs. We compared UCB1, UCB2, and BM and identified distinct gene expression patterns. Selected clusters were analyzed demonstrating that genes of multiple developmental pathways, such as transforming growth factor-␤ (TGF-␤) and wnt genes, and markers of early embryonic stages and mesodermal differentiation displayed significant differences among the MSC populations. In undifferentiated UCB1 cells, multiple genes were significantly up-regulated (p Ͻ 0.0001): peroxisome proliferation activated receptor gamma (PPARG), which correlated with adipogenic differentiation capacities, hepatocyte growth factor (HGF), and stromal-derived factor 1 (SDF1/CXCL12), which could both potentially contribute to the higher growth kinetics observed in UCB1 cells. Overall, the results confirmed the presence of two distinct isogenic UCB-derived cell populations, identified gene profiles useful to distinguish MSC types with different lineage differentiation potentials, and helped clarify the heterogeneity observed in these cells.
INTRODUCTION M
ESENCHYMAL STEM/STROMAL CELLS (MSCs) are fibroblast-like cells that were first described several decades ago and found in bone marrow (BM) as precursors of nonhematopoietic tissue (1) . MSCs are self-renewing, multipotent cells that can differentiate into mesoderm-derived tissues, including cartilage, bone, fat, and muscle (2) (3) (4) (5) (6) . These plastic-adherent cells have been isolated from BM, adipose tissue (AT), peripheral blood in adults, and from umbilical cord blood (UCB) and cord stroma in neonates (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Currently, the major source of MSCs for both experimental and clinical studies is BM (18) (19) (20) (21) , but MSCs from UCB have also shown promise (22, 23) . Several questions remain about the heterogeneous origins and biological properties of MSCs, and a standard nomenclature has been proposed (24, 25) .
UCB is already a widely accepted source of hematopoietic stem and progenitor cells, and transplants have been performed for a number of malignant diseases (26) . Recently, UCB collected either immediately after birth or from frozen banked samples has been explored as an alternative noninvasive source of multipotent MSCs capable of in vitro differentiation toward mesenchymal cell lineages (12) (13) (14) (15) (16) 27) . However, isolation of multipotent MSCs from full-term UCB has been inconsistent (28, 29) , although a number of groups (including ours) have successfully isolated them (12) (13) (14) (15) (16) .
Although BM-and UCB-derived MSCs appear, in general, to have similar potential for differentiation (4) (5) (6) (7) (8) (12) (13) (14) (15) (16) ), significant differences have also been observed. In fact, it was recently reported that UCB contains a rare population of adherent somatic stem cells (average 4 colonies 1 ϫ 10 9 nucleated cells) with a pluripotent potential for differentiation, including MSC-like features (15, 30) . In addition, adherent colonies expressing embryonic stem (ES) cell markers have also been reported in UCB (31) . UCB MSCs have been shown to have greater differentiation capability than BM MSCs toward the osteogenic lineage (32, 33) . The recent finding of two clonogenic UCB mesenchymal progenitor cell types (34) may explain the observed variability for adipogenic differentiation in UCB MSCs (32, 34, 35) . MSCs are observed at a much lower frequency in UCB than in BM, approximately 1:10 8 for UCB and 1:10 5 in BM mononuclear cells (3, 4, 12, 13) . The limited presence of MSCs in UCB allowed us to readily isolate and characterize single colonies originating from a single MSC, even from within the same UCB unit.
In this study, single isogenic UCB MSC colonies (UCB1 and UCB2) were used to identify specific genes that may underlie the observed MSC heterogeneity and differences in potentialities. The cellular phenotype, potential for differentiation, and patterns of gene expression were also analyzed for these MSC types. Moreover, we compared expression profiles of the distinct UCB1 and UCB2 populations to BM MSCs, the source of MSCs most often used for clinical studies (18) (19) (20) (21) . Further analysis of isogenic MSC isolates may help identify markers for selection of the most desirable populations for therapeutic use and also to understand their differences during cell lineage differentiation.
MATERIALS AND METHODS

Collection of UCB
UCB samples were harvested at birth from full-term deliveries after parental consent, under an Institutional Review Board-approved protocol to the New Jersey Cord Blood Bank (NJCBB), located within the Coriell Institute for Medical Research. After removal of the placenta, blood was collected within the first 10 min of delivery and drained from the distal end of the umbilical vein by gravity into a plastic bag containing 25 ml of citrate phosphate dextrose anticoagulant solution (Medsep Corporation, Covina, CA).
UCB MSC isolation, culturing, and expansion
UCB samples were stored at room temperature, and units considered nonbankable due to low volume (net volume Ͻ 40 ml) were processed within 24 h of delivery. The UCB samples were layered carefully on 20 ml of Histopaque (Sigma-Aldrich Corp. St. Louis, MO; http:// www.sigmaaldrich.com) and centrifuged at 1,250 ϫ g for 25 min at 20°C. The interface layer was collected, diluted with 20 ml of phosphate-buffered saline (PBS) (Invitrogen, Carlsbad, CA; http://www.invitrogen.com) and further centrifuged at 500 ϫ g for 10 min. Cells were washed in PBS and centrifuged at 350 ϫ g for 5 min (36) . Cell counts were performed using an automated cell analyzer (Cell-Dyn 1700, Abbott Park, IL). UCB mononuclear cells (MNCs) were seeded in separate fibronectin-coated (5 ng/ml) culture dishes (VWR International, Bridgeport, NJ; http://www.vwr.com) or T-75 flasks (Corning Incorporated, Corning, NY; http://www. scienceproducts.corning.com) at a density of 0.5-1 ϫ 10 6 cells/cm 2 in Dulbecco's modified Eagle medium (DMEM) high glucose with 10% fetal bovine serum (FBS) in the presence of 1% penicillin-streptomycin. After 5-7 days of incubation at 37°C in a humidified atmosphere containing 5% carbon dioxide, the culture medium was replaced and nonadherent cells were removed. The medium was changed twice weekly. When MSC colonies were identified, they were left to grow for 10-15 days and detached with 0.05% trypsin for 2 min at confluency. Typically, only one MSC colony (or no colonies) developed per culture dish. In cases where we had more than MARKOV ET AL. one colony per culture dish, we used cloning cylinders (Corning) and low-concentration trypsin 0.05% (Sigma) to obtain single isolated colonies of MSCs. The cells were then seeded at a density of 6,000-10,000 cells/cm 2 and expanded in DMEM high glucose with 10% FBS.
In addition, using a modified separation technique for low volume UCB (Ͻ40 ml) units, we have significantly increased the recovery of MNCs (patent pending), and isolated 27 additional colonies from 11 donors (V. Markov and B. Saitta, unpublished data). Briefly, each unit was diluted with an equal volume 1ϫ PBS (Invitrogen), layered in a 1:1 ratio (vol/vol) on Histopaque (Sigma) in 50-ml plastic tubes and after centrifugation at 500 ϫ g for 30 min at 21°C, the plasma was aspirated leaving 3-5 ml above the interface. The entire buffy coat layer was collected together with the adjacent layer immediately above it (3-5 ml of plasma) and the immediate lower layer (3-5 ml Histopaque). The cell suspension was diluted in a ratio of 1:1.5 (vol/vol) with 1ϫ PBS and centrifuged at 500 ϫ g for 10 min at 21°C. PBS was aspirated leaving approximately 5 ml above the cell pellet. A second wash was performed with 40 ml of 1ϫ PBS and the cells were centrifuged at 350 ϫ g for 5 min at 21°C. The PBS was again aspirated, leaving 1-2 ml above the cell pellet that was resuspended in DMEM low glucose with Glutamax (Invitrogen) supplemented with 30% FBS (Sigma), 1% penicillin-streptomycin (Sigma), and 1 ϫ 10 Ϫ7 M dexamethasone (Sigma), and cultured as described above.
Growth kinetics and colony-forming unit fibroblast assays
Cumulative population doubling levels at each passage were calculated from the cell count by using the formula: [log 10 (N H ) Ϫ log 10 (N I )]/log10(2) ϭ x, where N H ϭ cell harvest number, N I ϭ inoculum number, and x ϭ population doublings. The population doubling increase that was calculated was then added to the previous population doubling level to yield the cumulative population doubling level (37) . Cell cultures were considered senescent when subcultivations did not result in at least one cell population doubling after 3 weeks in culture. BMderived MSCs (Lot #4F0312) were purchased from Cambrex, grown using the same cell culture conditions as UCB-MSCs, and assayed at passage number 5. Measurements of cell length and width were made with an eyepiece micrometer, and mean Ϯ standard errors were calculated.
To assess the ability of the MSCs to generate colonyforming unit fibroblast (CFU-F), the cells were harvested with 0.05% trypsin-EDTA, dissociated, counted, and plated at a density of 3 cells/cm 2 in T-25 flasks (Corning) in DMEM high glucose (Invitrogen) and 10% FBS (38, 39) . After 15 days incubation at 37°C with 5% humidified CO 2 , the colonies were stained with 0.5% crystal violet (Sigma) in methanol for 10 min at room temperature (38) . The purple colonies were counted to determine CFU-F formation, either visually or under low magnification by standard microscopy (39) .
Karyotyping of UCB1 and UCB2 MSCs
Giemsa-banding was performed on metaphase spreads of the cells according to standard procedures (40) . The cells were plated in a T-25 flask (Corning) at a density of 6,000 cells/cm 2 in DMEM high glucose supplemented with 10% FBS (Sigma). When the cells appeared to be highly mitotic, chromosomes were exposed to colcemidKaryoMAX (Invitrogen) and harvested. Hypotonic treatment with 0.4% KCl: 0.7% sodium citrate (2:1) for 15 min at 37°C was followed by fixation with methanol: acetic acid (3:1). Chromosomes were G-banded using trypsin (Sigma) followed by staining with Wright's stain. Cytogenetic analysis of 20 G-banded metaphase cells of each MSC type was performed to assess for chromosomal rearrangements.
Induction and quantitative analysis of MSC differentiation
To induce adipogenic differentiation, we used a method previously described (9) . In brief, induction medium containing 1 M dexamethasone, 10 M recombinant human insulin, 200 M indomethacin, 0.5 mM 3-isobutyl-1-methyl-xanthine (Sigma), 1% penicillin-streptomycin, and 10% FBS (Sigma) in DMEM (Invitrogen) was used (9) . Adipocytes were identified by Oil Red O staining (Sigma). Osteogenic differentiation was induced by culturing the cells for 2 weeks in osteogenic media (41) containing 0.1 M dexamethasone, 50 M ascorbate-2-phosphate, 10 mM ␤-glycerophosphate (Sigma), 1% penicillin/streptomycin, and 10% FBS in DMEM (Invitrogen). The medium was changed every 3-4 days and stained with the von Kossa reagent to detect extracellular matrix calcification (41) and also assayed for alkaline phosphatase activity (9) . For chondrogenic differentiation, a pellet culture technique was used (42) . Approximately 250,000 MSCs were centrifuged at 450 ϫ g for 10 min in a 15-mL polypropylene tube and cells were stimulated with human 10 ng/ml of transforming growth factor-␤3 (TGF-␤3) (PeproTech Inc.) (8), 50 M ascorbate-2-phosphate, 10 M recombinant human insulin, and 1% FBS (Sigma) in DMEM (Invitrogen) and cultured for 14 or 21 days (42) . Cell pellets were fixed and embedded in paraffin following the manufacturer's protocol (Dako Cytomation). Sections were incubated with COL2A1 antibody (University of Iowa Hybridoma Bank) and detected using Vectastain ABC and peroxidase substrate followed by counterstaining MSC POPULATIONS IN CORD BLOOD with Methyl Green (Vector Laboratories). All assays were photographed using a Leica DMLB microscope equipped with a CoolSNAPcf™ camera and Nikon ACT-1 version 2.20 software.
Quantitative analysis experiments of MSC (UCB and BM) differentiation were performed in triplicate, and the values were normalized to the DNA content from the same culture dish. In brief, for adipogenic differentiation, the amount of Oil Red O was extracted and compared to an Oil Red O standard titration curve. Osteogenic differentiation was quantified by measuring calcium deposition using an Alizarin Red standard curve and determined spectrophotometrically at 550 nm (43) . For chondrogenic differentiation, glycosaminoglycan content was quantitated using dimethylmethylene blue (DMB) solution (ratio 1:10) for sulfated polysaccharides and absorbance at 535 nm (A 535 ) was read. The A 535 value was compared with a standard curve prepared using chondroitin-4 sulfate mixed with the same volume of dye (44) .
Flow cytometry and immunofluorescence microscopy
UCB MSCs grown in culture were assayed by flow cytometry, as previously described (8) . In brief, cells were harvested by centrifugation, washed in PBS containing 0.1% bovine serum albumin (BSA; Sigma), and incubated for 20 min at room temperature with primary antibody. After they were washed three times with 0.1% BSA/PBS, cells were incubated with conjugated secondary Alexa Fluor 488 goat anti-mouse immunoglobulin G 1 (IgG 1 ) and phycoerythrin (PE) goat anti-mouse IgG 2b antibodies (Molecular Probes), washed again, and fixed with 2% paraformaldehyde (Sigma). The cell aggregates were removed by passing through 70-m nylon mesh (Sefar). At least 10,000 events were acquired and fluorescence was analyzed using an Epics Elite ESP flow cytometer (Beckman/Coulter). Mouse monoclonal antibodies (mAbs) against CD31, CD44, CD45, COL1A1, FN1, and hybridoma cell lines producing mAbs against CD34, CD73, CD90, and CD105 were purchased from the University of Iowa Hybridoma Bank. Monoclonal antibodies against CD11b and CD29 were obtained from BD PharMingen. Immunofluorescence analysis was carried out as described previously (14) . Cells were tested at passage 6 for all the above markers, except for CD31 and CD45, which were assayed at passage 12 of the UCB MSCs.
Quantitative analysis of gene expression
For the three biological replicates analyzed for each cell type: UCB1 was assayed at passage numbers 10, 11, and 13; UCB2 at passage numbers 9, 10 and 13; and BM at passage number 5. Total RNA was isolated from cells in culture using the RNAeasy Mini Kit (Qiagen). Microarray target was prepared following the manufacturer's protocol. In brief, cDNA was synthesized from total RNA using the SuperScript II double-stranded cDNA synthesis kit (Invitrogen), followed by in vitro transcription, where labeled cRNA was generated (Enzo). Hybridizations were carried out on Affymetrix HG-U133A and B arrays.
The data (.CEL files) from the A arrays were processed and gene expression levels were estimated using the robust multiarray average (RMA) method (45) implemented in BioConductor (http://www.bioconductor.org), an open source software package for genomic data analysis based on the R programming language (http://www. cran.r-project.org). The RMA procedure uses convolution background correction, quantile normalization, and a robust multiarray model to estimate expression levels. It produces expression measures on a log (base 2) scale. We set the threshold for reliable detection to log 2 50 and removed probe sets that were below the threshold in all samples. A total of 11,404 probe sets were kept for further analysis. To detect differences in gene expression across the three cell types, an analysis of variance (ANOVA) model was fit on each probe set. This raises a problem of multiplicity, where the probability of declaring significance erroneously increases with the number of tests performed. We used the Benjamini and Hochberg (46) false discovery rate (FDR) procedure to adjust for multiple testing. The FDR approach controls the expected proportion of false rejections among the total number of rejections. Once differentially expressed probe sets were identified, we applied hierarchical clustering to the selected set to identify groups of genes with similar expression patterns. The statistical analyses were conducted using version 2.2.1 of the R statistical software.
For standard RT-PCR analysis, cDNA was synthesized using Super Script III (Invitrogen) and specific primers were used for COL2A1 (47) and ACTB (48) . For quantitative PCR analysis, real-time PCR (Applied Biosystems) was used with commercially available assays for CDKN2A (Hs00233365_m1), COMP (Hs00164359_m1), CTGF (Hs00170014_m1), HGF (Hs00300159_m1), HHEX (Hs00242160_m1), and ZIC1 (Hs00602749_m1) and performed on an SDS-7000 thermocycler (Applied Biosystems). Additionally, using SYBR Green PCR master mix and an ABI PRISM 7900HT Fast Real Time PCR System (Applied Biosystems), quantitative PCR analysis, as previously described (49), was performed for: CD90/ THY1, forward, 5Ј-TGCAGAGATCCTACTTCTCTGA-GTCA-3Ј, reverse, 5Ј-CCCACTTCTCCTCAAGGTTT-GA-3Ј (71 bp); CXCL12/SDF1, forward, 5Ј-CATGCCG-ATTCTTCGAAAGC-3Ј, reverse, 5Ј-CAGTTTGGAGT-GTTGAGAATTTTGA (73 bp); PPARG, forward, 5Ј-GG-CTTCATGACAAGGGAGTTTC-3Ј, reverse, 5Ј-AACT-MARKOV ET AL.
CAAACTTGGGCTCCATAAAG-3Ј (74 bp); GAPDH, forward, 5Ј-CCTCCCGCTTCGCTCTCT-3Ј, reverse, 5Ј-CTGGCGACGCAAAAGAAGA-3Ј (64 bp). Primers were designed with Primer Express 1.5a software (Applied Biosystems), and their product size in base pairs (bp) is shown in parentheses.
Accession numbers
Data sets from the Affymetrix HG-U133A and HG-U133B microarray analysis of the nine RNA samples are deposited at the Gene Expression Omnibus (http://www. ncbi.nlm.nih.gov/geo; accession number GSE6029).
RESULTS
Isolation and characterization of distinct MSC populations from the same UCB sample
We screened samples of freshly harvested UCB from full-term deliveries for MSCs, which can be identified as single colonies of adherent spindle-shaped cells. In culture, UCB MSCs have been found at a very low frequency (approximately 1:10 8 ) among UCB MNCs (12, 13) . From the same UCB sample, we demonstrate that it is possible to isolate two distinct adherent colonies (UCB1 and UCB2) in separate culture dishes (Fig. 1A,B) . Each population initially displayed a spindle-shaped morphology; however, UCB1 cells were small and elongated (Fig. 1A , passage 1), whereas UCB2 cells were larger and flattened (Fig. 1B, passage 1 ). These distinct morphologies were maintained through all passages (not shown). Additionally, the cell populations demonstrated differences in growth dynamics. UCB1 cells reached 100% confluence in 5 days (Fig. 1A) , while UCB2 cells grew in focal patches and did not reach full confluence (Fig. 1B) . In the first 14 days in culture, UCB1 and UCB2 cells differed in doubling time and in the number of passages generated (Fig. 1C,D) . UCB1 cells showed a plateau in their doubling after 50 times in 19 passages (doubling time 1.0-2.1 days; Fig. 1C,D) , whereas UCB2 cells reached a plateau after only 30 doublings in 13 passages (doubling time 1.2-2.5 days; Fig. 1C,D) . Similar results were obtained with another single donor unit, and also in UCB samples from different unrelated donors. In fact, using a modified separation technique (patent pending) for lowvolume UCB units (Ͻ 40 ml), we have isolated an additional 27 colonies from 11 donors. During expansion, approximately two-thirds of the single isolated colonies maintained the large flattened morphology, with the remaining third showing the spindle-shaped morphology (V. Markov and B. Saitta, unpublished data).
Under identical CFU-F assay conditions (37), both UCB cell types displayed significant differences. When plated at a density of 3 cells/cm 2 , UCB1 cells formed large colonies ( Fig. 1E ) with an average efficiency of 31% ( Fig. 1G ) whereas UCB2 cells formed smaller colonies (Fig. 1F ) and produced CFU-F with an efficiency of 9% ( Fig. 1G ) (n ϭ 3 replicates). Overall, CFU-F efficiency was significantly higher (p Ͻ 0.05) in UCB1 and BM types compared to UCB2 cells (Fig. 1G ). The differences in cell growth, morphology, and CFU-F observed between UCB1 and UCB2 cells were not associated with chromosomal rearrangements. We examined 20 G-banded metaphase karyotypes of each cell type and did not detect any visible chromosomal rearrangements that might explain the phenotypic differences in culture (550 band resolution; Fig. 2 ).
UCB1 and UCB2 display quantitative differences in differentiation potentials
Both UCB1 and UCB2 cell populations exhibited differentiation capacities associated with multipotent MSCs (8, 9, 47) . Specifically, after adipogenic induction, we observed the accumulation of lipid vacuoles when stained by Oil Red O in both UCB1 and UCB2 cells (Fig. 3B,D) . After osteogenic induction, both UCB1 and UCB2 cells displayed von Kossa-stained calcium oxalate nodules (Fig. 3F ,H) and alkaline phosphatase-positive aggregates, seen as purple regions of staining (Fig. 3J,L) . Under chondrogenic induction conditions, both UCB1 and UCB2 cells displayed COL2A1 antibody staining in pellet culture ( Fig. 3N ,P), and both cell types were positive for COL2A1 mRNA by RT-PCR (Fig. 3Q) . Thus, both UCB1 and UCB2 cells are capable of adipogenic, osteogenic, and chondrogenic differentiation that is typical of MSCs.
To quantify the degree of differentiation, analysis of the MSC lineages was determined by spectrophotometric analysis ( Fig. 3R-T) . For the adipogenic differentiation, significant differences were found with UCB1 cells showing greater (p Ͻ 0.00001) differentiation potential toward this lineage than BM and UCB2; however, BM was higher (p Ͻ 0.01) than UCB2 cells (Fig. 3R ). In contrast, calcium deposition as a quantitative assessment of osteogenic lineage differentiation was stronger (p Ͻ 0.01) for the UCB2 cells compared to the other MSCs, but no differences were observed between UCB1 and BM cells (Fig. 3S) . Finally, for chondrogenic lineage differentiation BM MSCs demonstrated significantly greater (p Ͻ 0.05) chondrogenic potential than UCB1 or UCB2 types, and no significant differences were found between the UCB populations (Fig. 3T ). All quantitative differentiation assays were performed in triplicate and samples were normalized to their DNA content.
Immunophenotyping confirmed that UCB1 and UCB2 cells displayed the presence of defined MSC surface markers and the absence of hematopoietic and endothe-MSC POPULATIONS IN CORD BLOOD lial markers. Using flow cytometry, we found that both cell populations expressed the MSC surface markers CD29, CD44, CD73, CD90, and CD105 and neither of the UCB-derived cells stained for the hematopoietic markers CD11b, CD34, and CD45, nor for the endothelial marker CD31 (Fig. 4A-I ). Immunofluorescence assays confirmed that UCB1 and UCB2 cells expressed CD29, CD44, CD73, and CD90 as well as the extracellular matrix (ECM) proteins collagen type I (COL1A1) and fibronectin (FN1) (Fig. 4J-O) . Both cell types were negative for the hematopoietic marker CD45 and for the endothelial marker CD31 (data not shown). Thus, immunophenotyping confirmed that both UCB1 and UCB2 cells displayed cell-surface markers characteristic of MSCs.
Microarray analysis of developmental gene expression profiles for UCB1 and UCB2 MSCs
To identify developmental genes whose patterns of expression distinguished UCB1 and UCB2 MSCs, we carried out microarray analysis using the Affymetrix HG-MARKOV ET AL.
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FIG. 1.
Characterization of distinct UCB-derived MSCs populations with different morphology and growth kinetics. By phasecontrast microscopy, UCB1 cells (A) are spindle-shaped, small cells that grow to confluence, whereas UCB2 cells (B) are larger and grow in focal patches (passage 1 for both cells). This morphology was maintained through all population doublings. The magnifications shown are 40ϫ and 200ϫ (black bar ϭ 15 m). UCB1 cells doubled more than 50 times in culture and grew for 19 passages, whereas UCB2 cells doubled less than 30 times for 13 passages (C). Average cell doublings per 24 h over several passages is shown for all three replicates of UCB1 and two replicates of UCB2 cells (D). The CFU-F assay shows large colonies (E) and a colony-forming efficiency of 31% for UCB1 cells (G; for n ϭ 3 at passage numbers 7-8, corresponding to 29 population doublings), whereas the UCB2 cells show smaller colonies (F) and an efficiency of 9% (G; for n ϭ 3 at passage numbers 8-9, corresponding to 26 population doublings). Significantly higher CFU-F efficiency (p Ͻ 0.05) was observed in UCB1 and BM compared to UCB2. Data are shown as mean Ϯ standard deviation of the mean (G).
U133 platform. For comparison, adult BM-derived MSCs were analyzed using the same cell culture conditions and confluence as UCB MSCs. RNA was prepared from three biological replicates for UCB1, UCB2, and BM MSCs, for a total of nine samples analyzed on the HG-U133A and HG-U133B arrays.
To detect differentially expressed genes across the three cell types, we carried out ANOVA on each of the 11,404 probe sets that passed the filtering criterion. We controlled the FDR at a 0.01 level, and we identified 2,085 probe sets with a significant main effect, that is, probe sets for which at least one cell type was significantly different from the others. The cell type-specific differential expression for these probe sets is summarized with the Venn diagram in Fig. 5A . Of the 2,085 probe sets, 121 were significantly different among all three cell types with p values Ͻ0.001 for each pairwise contrast. Similarly, there were 589 probe sets that were "specific" to BM versus the other two cell types; 349 probe sets were differentially expressed in UCB1 compared to BM and UCB2, and there were 221 differentially expressed sets in UCB2 relative to each of the other cell types. Additionally, there were 420 probe sets that were significantly different only between BM and UCB1 (i.e., the contrasts between BM vs. UCB2 and UCB1 vs. UCB2 were not significant at a 0.001 level), and 223 were significantly different only between BM and UCB2. Finally, 162 sets showed significant differences only between UCB1 and UCB2. Given the capacity of UCB1, UCB2, and BM MSCs to differentiate toward multiple cell lineages, we were particularly interested in which developmental genes [ Table 1 , (1-4)] were expressed at significant levels (FDR of 0.01). In particular, we analyzed UCB1, UCB2, and BM microarray data to identify genes that were differentially expressed in at least one of the three cell types. An examination of genes expressed in early mammalian development was performed, including those associated with the blastocyst inner cell mass (ICM) stage and markers specific to ES cells. We observed expression of POU5F1/OCT4, a key marker of the ICM, the canonical wnt pathway gene ␤-catenin (CTNNB1), GATA6, leukemia inhibitory factor (LIF), STAT3, and the polycomb gene SUZ12 (Table 1 ). In addition, we examined genes expressed during and immediately after gastrulation, the process that generates the mesodermal germ layer from which cartilage, bone, skeletal muscle, and adipose tissue are all derived. The anterior visceral endoderm specifies the anterior-posterior body axis, and we observed higher levels of expression of the homeobox marker HHEX in UCB1 cells (Table 1 and Fig. 6D ). The node is a key organizer of mesoderm formed in the primitive streak, and we found that expression of WNT5a and the TGF-␤ pathway gene follistatin (FST) was also significantly higher in UCB1 cells. Paraxial mesodermal markers expressed in MSCs included ephrin receptor A4 (EPHA4), the notch receptor NOTCH2, and the zinc finger transcription factor snail (SNAI1). However, many genes in the notch and wnt pathway genes specific to paraxial mesoderm were below threshold of detection in the MSCs examined ( (9-11) ]. The peroxisome proliferation-activated receptor gamma (PPARG), an adipogenic marker, was significantly higher (p Ͻ 0.0001) in UCB1 compared to UCB2 and BM. These data might correlate with the significantly stronger adipogenic differentiation capacity observed in UCB1 (Fig. 3R) . In contrast, markers for chondrogenic differentiation that were above the threshold of detection in uninduced MSCs, such as aggrecan 1 (AGC1), collagen X (COL10A1), and cartilage oligomeric protein (COMP), showed significantly greater expression levels (p Ͻ 0.0001) in BM compared to the UCB-MSCs (Table 1) . COMP expression has also been evaluated and validated by real-time PCR assays (Fig. 6K) . These results correlate with the greater chondrogenic capacity observed in BM compared to the UCB MSCs (Fig. 3T) . Moreover, we have analyzed gene expression levels of osteogenic markers although most of them (ALPL, IBSP, and SPP1) were below the threshold of detection (Table 1, bottom) or showed similar levels (RUNX2) among the MSCs. However, the osteogenic marker SPARC/osteonectin was expressed at high levels in all uninduced MSCs (Table  1) . Although significantly higher in BM, we were not MARKOV ET AL.
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FIG. 3.
Identification of quantitative differences in differentiation potential between UCB MSC populations, and also compared to BM MSCs. UCB1 and UCB2 MSC populations were assayed for adipogenic (A-D), osteogenic (E-L), and chondrogenic (M-P) differentiation. Induced cells were compared to control cells grown in DMEM-high glucose with 10% FBS medium. Cells (A-P) were detected by phase-contrast inverted microscopy after 2 and 3 weeks in culture. Adipogenic induction, assayed by Oil Red O-stained lipid droplets, is seen in induced UCB1 (B) and UCB2 (D) cells, but not in control cells (A,C). Osteogenic induction, as assayed by von Kossa staining is seen as dark regions in treated UCB1 (F) and UCB2 (H) cells, but not in untreated controls (E,G). Osteogenic induction, assayed alternately by alkaline phosphatase, is seen as purple regions of staining in treated UCB1 (J) and UCB2 (L) cells, but not in untreated controls (I,K). Chondrogenic differentiation, detected by COL2A1 antibody staining of pellet cultures, is seen in induced UCB1 (N) and UCB2 (P) cells, but not in control cells (M,O). To confirm expression of COL2A1 mRNA, UCB1 and UCB2 pellet culture samples were analyzed by RT-PCR (Q) using a COL2A1 assay (400 bp) compared with a ␤-actin (ACTB) control assay (662 bp). Lane identities are: lane 1, UCB1 cells grown in control medium; lanes 2 and 3, UCB1 cells induced for chondrogenic differentiation assayed at 14 and 21 days; lane 4, UCB2 cells grown in control medium; lanes 5 and 6, UCB2 cells induced for chondrogenic differentiation assayed at 14 and 21 days. To quantify the degree of differentiation spectrophotometric analysis of the different MSCs toward specific lineages were performed (R-T). Significant differences were found in adipogenic differentiation, with UCB1 cells showing greater (p Ͻ 0.00001) differentiation potential than BM and UCB2 types, with BM higher (p Ͻ 0.01) than UCB2 cells (R). Osteogenic lineage differentiation was stronger (p Ͻ 0.01) for the UCB2 cells compared to UCB1 or BM cells (S). No significant differences were observed for chondrogenic lineage differentiation between UCB1 and UCB2 populations, however BM MSCs demonstrated significantly greater (p Ͻ 0.05) chondrogenic potential than both UCB types (T). All differentiation quantitative assays (R-T) were performed in triplicate and samples were normalized to their DNA content. able to correlate this marker with the quantitative osteogenic differentiation data, as shown in Fig. 3S .
We then focused on 290 probe sets that were significantly different between UCB1, UCB2 and BM cell types at a 0.001 FDR level (Fig. 5B-E and Table 2 ). Using hierarchical clustering, several groups of gene expression patterns were identified, and selected clusters (I-IV) are graphically displayed as a heat map in Fig. 5B . Cluster I demonstrates a group of genes (with multiple probe sets) that were significantly up-regulated (p Ͻ 0.00001) in   FIG. 3. 
FIG. 4.
Flow cytometry and immunofluorescence demonstrate expression of MSC markers in UCB1 and UCB2 cell types. UCB1 and UCB2 MSC populations were harvested and analyzed by flow cytometry using specific monoclonal antibodies. Both cell types were positive for the mesenchymal surface markers CD29/ITGB1 (A), CD44 (B), CD73/NT5E (C), CD90/THY1 (D), and CD105/ENG (E), and both were negative for the hematopoietic markers CD11b/ITGAM (F), CD34 (G), and CD45 (H), nor for the endothelial marker CD31 (I). Flow cytometry results are shown with the background staining profiles (white peak; isotype control IgG) compared to specific antibody staining profiles (grey peak). By immunohistochemistry, both UCB1 and UCB2 cells were positive for CD29/ITGB1 (J), CD44 (K), CD73/NT5E (L), CD90/THY1 (M), and extracellular matrix proteins collagen type I (COL1A1; N), and fibronectin (FN1; O). The RMA-estimated gene expression levels from the Affymetrix HG-U133A arrays, averaged within each cell type, are shown (P). Levels of probes shaded with dark gray boxes correspond to expression estimates deemed reliable in at least one sample, while those without shading were found to be below the threshold (BT) for reliable detection in all samples. Table 2 ) with significant increased expression in UCB1 compared to UCB2 MSCs (C, Cluster I), and decreased (D, Clusters II and III)) or increased (D, Cluster IV) expression in UCB1 compared to UCB2 and BM MSCs. Table 2 .
Expression levels are provided on a log UCB1 compared to UCB2 MSCs, and included IGFBP5, FZD7, RHBDL2, DCN, SULF1, FBLN1, and SFRP1 ( Fig.  5C and Table 2 ). Many of these genes have been associated with embryonic development and organogenesis. Interestingly, most of the above genes also showed higher levels of expression in UCB1 compared to BM MSCs, except for DCN and SULF1 for which the latter was upregulated in BM cells (Table 2) . Clusters II-IV shared similar patterns of gene expression differences between UCB1 and the other two MSCs (UCB2 and BM). Clusters II and III mostly included genes that are significantly decreased in expression levels in UCB1 populations compared to UCB2 and BM MSCs (Fig. 5D and selected genes listed in Table 2 ). Genes in these clusters include the TGF-␤ pathway ligands TGFB1 and inhibin/activin-A (INHBA), the inhibitor SMAD7, and the type 1 receptor inhibitor BAMBI. However, the TGF-␤/activin inhibitor gene follistatin (FST) also clustered in group II, but showed slightly increased expression in UCB1 (Table 2) . Lower levels of expression in UCB1 were observed for vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF). In addition, many extracellular molecules are decreased in UCB1 including the SPOCK and CSPG2 proteoglycans, adhesion molecule AMIGO2, bone marrow stromal cell antigen BST1, collagen VIII alpha 1, and cell-surface glycoprotein and cadherin 11 (CDH11). Conversely, we identified clusters containing genes that were significantly increased in expression levels in UCB1, compared to UCB2 and BM MSCs. In Cluster IV (Fig. 5E , Clusters IVa and IVb, and Table 2 ), we observed many transcription factors and ligands in different developmental pathways, including the wnt genes WNT2, WNT5A, the T-box gene TBX3, the homeobox genes SIX1, PITX1, HOXD11, HHEX, the forkhead gene FOXF1, and the ligand BMP4. We also noted that UCB1 had higher levels of the glycoprotein protocadherin 7 (PCDH7), the ECM proteins laminin alpha2 (LAMA2) and collagen XVIII alpha 1 (COL18A1), and the EPH receptor A4 (EPHA4). Of particular interest was the increased expression level in UCB1 cells of hepatocyte growth factor (HGF), which is also known as scatter factor (Fig. 5E, Cluster IVa) . HGF is a mitogen that stimulates the dissociation and scattering of epithelial cells, and was previously suggested in human MSCs to play a role in tissue repair and wound healing (50) .
To confirm that the gene expression differences detected by microarray analysis of three biological replicates could be validated by alternate methods, we carried out quantitative PCR (q-PCR; Taqman Real-time PCR or SYBR Green PCR master mix, Applied Biosystems) on 11 representative genes. We examined hepatocyte growth factor HGF, the adipogenic marker PPARG, basic helix-loop-helix (bHLH) transcription factor ID1, the homeobox gene HHEX, the zinc finger gene ZIC1, the tumor suppressor gene CDKN2A/p16, mesenchymal stem cell marker CD90/THY1, stromal-derived factor (SDF-1/CXCL12), connective tissue growth factor CTGF, and cartilage oligomeric protein COMP, as shown in Fig. 6 . q-PCR results were consistent with microarray findings, with realtime PCR quantitative results showing more sensitivity to threshold detection-level effects. In addition to this validation, microarray data were also consistent with results from protein-based flow cytometry and immunohistochemistry assays as demonstrated by several markers: CD29/ITGB1, CD44, CD73/NT5E, CD90/THY1, CD105/ENG, COL1A1, and FN1, which were above the threshold, and CD11b/ ITGAM, CD31/PECAM1, CD34, and CD45/PTPRC, which were below threshold (log 2 50; Fig. 4P ).
DISCUSSION
In this study, we have isolated phenotypically distinct isogenic UCB MSC populations (UCB1 and UCB2) from the same tissue source, and observed differences in morphology, expansion potential, CFU-F efficiency, and in differentiation capacity. To identify the MSC-specific and developmental genes associated with these phenotypic differences, we then used Affymetrix HG-U133 microarrays, and compared our UCB MSCs to human BM MSCs.
Previous reports have demonstrated the existence of adherent mesenchymal cell types with distinct morphologies, replication, and differentiation potentials found in cultured human bone marrow (8, 38, 51, 52) . Similar cells were obtained by fractionating human peripheral blood (10, 11) and from human placenta (53) . In addition, UCB-derived mononuclear cells were shown to give rise to two different adherent cell types: One showed fibroblastic morphology, formed colonies, expressed MSC-related surface antigens, and was capable of differentiating into osteoblast and adipocyte lineages. The other cell type, instead, displayed a morphology and cytochemical characteristics of multinucleated osteoclasts (12) . Very recently, clonogenic mesenchymal progenitor cells (MPCs) were isolated from UCB by a limiting dilution method (34). These cells exhibited two different morphologic phenotypes, including flattened fibroblasts (93% of the clones) and spindle-shaped fibroblasts (7% of the clones) with the growth rates comparable between flattened and spindle-shaped cells. One MSC-related marker (CD90/THY1) was expressed only in the spindle-shaped cells, but not in the flattened type. Although both cell types exhibited similar dual-lineage osteogenic and chondrogenic potential, only the CD90-expressing MPC type was capable of differentiation into an adipogenic lineage (34) .
The UCB1 and UCB2 cells described here are also phenotypically distinct populations, but we found different features from the previously reported MPC types described above. Our spindle-shaped UCB1 cells were MARKOV ET AL. Underlined genes are shown in Fig. 4 .
a Genes with multiple probes in each cluster. small, grew to a high density, and layered over each other (Fig. 1A) . In contrast, UCB2 cells were larger and flattened, but showed areas of focal confluence (Fig. 1B) . UCB1 and UCB2 types were also different in their growth kinetics (Fig. 1C ) and CFU efficiency (Fig. 1G) , and both were capable of differentiating into adipogenic, osteogenic, and chondrogenic lineages ( Fig. 3A-P) . Using quantitative analysis assays, we demonstrated a stronger adipogenic differentiation potential in the UCB1 cells in comparison to the UCB2 type (Fig. 3R) , whereas the differentiation capacity toward the osteogenic lineage was higher for the UCB2 cells (Fig. 3S ), but no significant differences toward the chondrogenic potential of the induced UCB1 and UCB2 populations was found (Fig. 3T) . Additionally, unlike the MPCs (34), our UCB1 and UCB2 MSCs were both found to express the mesodermal marker CD90/THY1, which was shown using fluorescence-activated cell sorting (FACS), immunofluorescence microscopy, microarray expression levels (Fig.  4D ,M,P), and validation by real-time PCR assays (Fig.  6H) . Therefore, the adipogenic potential of the UCB MSCs we studied did not correlate with the level of expression of CD90/THY1, as previously reported for the MPCs (34) . It has been demonstrated that subpopulations of rapidly self-renewing BM-derived MSCs, either positive or negative for the CD90 marker, are able to differentiate into adipogenic lineages (38) . Using microarray and real-time PCR assays, we found higher expression levels of the adipose-specific gene PPARG in the uninduced UCB1 compared to the uninduced UCB2 or BM cells (Table 1 and Fig. 6B ). PPARG is a specific transcription factor of adipose tissue with an important role in adipogenesis and is expressed during adipogenic differentiation of multipotent stem cells (4, 9) . Although Chang et al. (34) did not detect PPARG in uninduced MPC populations, they reported higher levels of its expression in the spindle-shaped adipogenic differentiated lineages compared to the flattened MPC type. We also found that the spindle-shaped UCB1 populations had significantly stronger PPARG expression when compared to the more flattened UCB2 type, and both uninduced cells (Fig. 6B) . These data correlate with our quantitative adipogenic differentiation data for the UCB populations (Fig. 3R) . The quantitative analysis of osteogenic differentiation determined by calcium deposition was stronger in UCB2 compared to UCB1 or BM MSCs, but no differences were observed between UCB1 and BM cells (Fig. 3S ). However we were not able to correlate these results to the microarray expression levels of the osteogenic markers ( Table 1 ). The transcription factor CBFA-1/RUNX2 that induces expression of several osteogenic genes (54) showed similar low levels in all our noninduced MSCs. In fact, most of the osteogenic markers (ALPL, IBSP, and SPP1) were below the threshold of detection, and only SPARC/osteonectin was expressed at high levels overall in our MSCs. Given these detection levels, it was difficult to identify specific markers associated with osteogenic differentiation potential in uninduced MSCs. Overall, these findings suggest that the conflicting reports for the adipogenic and osteogenic differentiation potential of UCB-derived MSCs (14, 15, 32, 33, 35, 55) might be explained by the presence of distinct MSC populations (34 and this report). Finally, we did not find significant differences in chondrogenic differentiation potential, measured by glycosaminoglycan secretion, between our UCB populations (Fig. 3T) . However, BM MSCs demonstrated a significant increase in chondrogenic potential compared to UCB1 or UCB2 populations, correlating to higher expression levels (p Ͻ 0.0001) of the chondrogenic markers collagen X (COL10A1), aggrecan 1 (AGC1), and cartilage oligomeric protein BM cells (Table 1 and Fig. 6K ). To understand better the observed differences in our UCB types (Fig. 3) , we are currently investigating which of the above differently expressed markers might play a crucial role during the various processes of differentiation into the adipogenic, chondrogenic, and osteogenic lineages (data not shown).
Next we defined developmental gene expression profiles characteristic of each UCB MSC type. A recent, microarray analysis of UCB-derived MSCs using the Amersham CodeLink array platform identified 47 genes that were highly expressed in UCB MSCs as compared to CB mononuclear cells (56) . Six of these 47 genes encode hypothetical proteins and, of the 41 remaining genes, 31 had representative probe sets on the HG-U133 array and were found to be present in UCB1, UCB2, and BM MSCs, except for one, lumican, which did not pass our threshold for reliable detection in the UCB1 samples (not shown). In another study, gene expression of UCB, adipose tissue, and BM-derived MSCs from four different donors were performed using a spotted cDNA microarray (55) . Although these data (55) cannot be directly compared with our Affymetrix platform, 9 of the 25 genes shown as up-regulated in MSCs versus human fibroblasts were also expressed in our UCB1, UCB2, and BM populations (AGTR1, CSPG2, FN1, HNRPM, ID1, PLOD2, PSPH, SEC13L1, TM4SF1). Moreover, in the prior report, MSCs were cultured in different media, which may affect gene expression. In contrast, we carried out experiments using two genetically identical UCB and one BM MSC line that were grown in the same medium. Therefore, our approach has greatly extended the ability to compare directly the developmental genes that are associated with specific phenotypic differences in UCB-derived MSCs.
Our microarray analysis has clearly demonstrated that there are significant differences in expression profiles of developmental genes among UCB1, UCB2, and BM MSCs (Figs. 5 and 6; Tables 1 and 2 ). Of particular interest are the genes that are up-or down-regulated in UCB1 MSCs due to their enhanced growth kinetics. Specifically, we found that genes in the TGF-␤ pathway showed significant differences between UCB1 and UCB2, including the ligand TGFB1, the inhibin/activin-A molecule (INHBA), the activin-inhibitor follistatin (FST), the SMAD7 inhibitor, and the type 1 receptor inhibitor BAMBI (Fig. 5D , Clusters II and III). The TGF-␤ signaling pathway plays crucial roles in the cell cycle, apoptosis, cell proliferation, and differentiation processes that are key both to early development and differentiation as well as for wound healing and regeneration (57) . Given these functions, it is perhaps not surprising that gene members of the TGF-␤ signaling pathway regulating musculoskeletal tissue development displayed significant differences in expression level between UCB1 and UCB2 or BM MSCs (Table 2 , clusters II and III).
Many cell-surface and ECM molecules were down-regulated in UCB1, including SPOCK and CSPG2 proteoglycans, adhesion molecule AMIGO2, BM stromal cell antigen BST1, collagen VIII alpha 1, and the cell-surface glycoprotein cadherin 11. Also, genes from multiple developmental pathways of differentiation were increased in UCB1, including the wnt genes WNT2, WNT5A, the T-box gene TBX3, the homeobox genes SIX1, PITX1, HOXD11, HHEX, the forkhead gene FOXF1, and the ligand BMP4 (Figs. 5 and 6 ; Tables 1 and 2 ). This pattern suggests that UCB1 cells may be a more "primitive" MSC type (58) , correlating with its faster growth kinetics profile and ability to expand to higher passage numbers. For all of the above reasons, the UCB1 MSCs display traits that may be desirable for therapeutic use. Previously, Kogler et al. (15) reported the identification of CB-derived unrestricted somatic stem cells (USSC) capable of pluripotent differentiation potential, including mesodermal, hematopoietic, and neural cell lineages. Although very rare (average 4 colonies per CB unit containing ϳ1 ϫ 10 9 nucleated cells), these isolated USSC colonies grow rapidly for many passages without losing their pluripotency (15) .
In addition, we also observed that the expression of the stromal-derived factor (SDF-1/CXCL12), and the hepatocyte growth factor (HGF) were significantly different (p Ͻ 0.0001) in our UCB MSC populations (Fig. 6A,I ). Both SDF-1 and HGF have been shown to be involved in recruitment of UCB-derived MSCs to injured tissues (50) . Furthermore, using microarray analysis and realtime PCR assays, high levels of SDF-1 expression were found in BM MSCs (Fig. 6I) . Previously, it was reported that the most immature human BM MSC populations express higher levels of SDF-1/CXCL12 than more mature cell populations, correlating the gene's role in growth and development (59) , and in survival and migration of circulating tissue-specific progenitors for muscle, neural tissues, liver, and for postnatal tissue repair (60) . It has also been demonstrated that SDF-1/CXCL12 regulates the cell cycle of hematopoietic stem cells (61) and its transgenic expression enhances survival of hematopoietic stem/progenitor cells (62) . It is possible that the increased expression of both SDF-1 and HGF in UCB1 could potentially contribute to the higher growth kinetics and CFU efficiency observed in this circulating cell population.
In summary, these studies suggest that SDF-1/ CXCL12, HGF, and other genes described in this report, including PPARG, could be used to identify distinct populations of UCB MSCs and to understand their differences during cell lineage differentiation. Furthermore, our data show that single UCB MSC colonies from the same donor can be used to study developmental genes (Tables 1 and 2 ) and identify cluster of genes such as the TGB-␤ pathway (Table 2) , which may help explain the observed phenotypic heterogeneity among MSCs MARKOV ET AL. (4, 8, 34, 38, 58) . For UCB MSCs, it remains unclear whether UCB2 cells are at a later developmental stage than UCB1 cells, or if they perhaps derive from a common ancestor and have progressed along different lineages. However, this initial study prompts future characterization of distinct adherent nonhematopoietic cell populations in UCB, which include MSCs, USSC, and MPCs, significantly adding to the information currently available (63) . Further studies using our isolated and expanded single adherent UCB MSC colonies will help to refine gene expression profiles associated with fastergrowing cells, and in addition may distinguish UCB MSC types more suitable for therapeutic use as in vitro models of cell lineage differentiation.
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